Reilly Financial Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

Reilly Financial Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-500	Closed	-$10K	–	1055
2018 Q1	$10K	Hold	500	–	–	﹤0.01%	662
2017 Q4	$8K	Hold	500	–	–	﹤0.01%	711
2017 Q3	$10K	Hold	500	–	–	﹤0.01%	642
2017 Q2	$8K	Hold	500	–	–	﹤0.01%	699
2017 Q1	$6K	Hold	500	–	–	﹤0.01%	724
2016 Q4	$7K	Hold	500	–	–	﹤0.01%	624
2016 Q3	$12K	Hold	500	–	–	﹤0.01%	502
2016 Q2	$14K	Hold	500	–	–	﹤0.01%	447
2016 Q1	$16K	Hold	500	–	–	﹤0.01%	657
2015 Q4	$21K	Sell	500 -1,500	-75%	-$59.9K	﹤0.01%	600
2015 Q3	$70K	Hold	2,000	–	–	0.01%	325
2015 Q2	$92K	Buy	+2,000	New	+$94.9K	0.02%	301
2015 Q1	–	Sell	-2,000	Closed	-$63K	–	1393
2014 Q4	$63K	Buy	+2,000	New	+$58.5K	0.02%	238

Reilly Financial Advisors's IPXL Position: Q2 2018 in Review

Reilly Financial Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 500 shares — an estimated $10K sold.

Reilly Financial Advisors first reported a position in IPXL in Q4 2014 and held it in 13 quarters. The position peaked at $92K in Q2 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Reilly Financial Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Reilly Financial Advisors sold 500 Impax Laboratories, Inc. shares in Q2 2018, an estimated $10K.
Reilly Financial Advisors first reported a position in Impax Laboratories, Inc. in Q4 2014 and held it in 13 quarters.
Reilly Financial Advisors's Impax Laboratories, Inc. position peaked at $92K in Q2 2015.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Reilly Financial Advisors's 13F filing for Q2 2018, filed 18 Jul 2018.